OBJECTIVE: To evaluate the results of percutaneous endoscopic treatment of renal pelvic transitional cell carcinoma (TCC). PATIENTS AND METHODS: Ten patients (median age, 70 years; range 56-86) with a renal pelvic TCC were treated by percutaneous endoscopic resection. Seven had a normal contralateral kidney and were treated electively. RESULTS: Follow-up was from 3 to 77 months. There was one recurrence locally and one recurrence in the bladder. There have been no recurrences in the nephrostomy tract. CONCLUSION: We have shown that percutaneous resection of intrarenal TCC is a possible and safe technique. Further follow-up is needed to confirm its safety.
OBJECTIVE: To evaluate the results of percutaneous endoscopic treatment of renal pelvic transitional cell carcinoma (TCC). PATIENTS AND METHODS: Ten patients (median age, 70 years; range 56-86) with a renal pelvic TCC were treated by percutaneous endoscopic resection. Seven had a normal contralateral kidney and were treated electively. RESULTS: Follow-up was from 3 to 77 months. There was one recurrence locally and one recurrence in the bladder. There have been no recurrences in the nephrostomy tract. CONCLUSION: We have shown that percutaneous resection of intrarenal TCC is a possible and safe technique. Further follow-up is needed to confirm its safety.
Authors: Rao S Mandalapu; Mesut Remzi; Theo M de Reijke; Vitaly Margulis; J Palou; A Kapoor; Ofer Yossepowitch; Jonathan Coleman; Olivier Traxer; J Kyle Anderson; James Catto; Jean de la Rosette; Timothy O'Brien; Anthony Zlotta; Surena F Matin Journal: World J Urol Date: 2016-05-27 Impact factor: 4.226